🔴 Vivani Medical is trading 6.6% down today on profit-taking after its recent rally

Vivani Medical is trading 6.6% down at $1.46 in pre-market as investors lock in gains following a significant price surge.

• The stock is extending a pullback that began on July 9 after a sharp rally fueled by collaboration news with Novo Nordisk regarding Vivani’s long-acting drug implant platform.
• Current market weakness appears to be driven by profit-taking and consolidation rather than any new company-specific developments.
• The downward move follows a period of high volatility and increased trading volume linked to the company's recent strategic updates.